HK1208886A1 - Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma - Google Patents

Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma

Info

Publication number
HK1208886A1
HK1208886A1 HK15109503.4A HK15109503A HK1208886A1 HK 1208886 A1 HK1208886 A1 HK 1208886A1 HK 15109503 A HK15109503 A HK 15109503A HK 1208886 A1 HK1208886 A1 HK 1208886A1
Authority
HK
Hong Kong
Prior art keywords
subject
determining
high grade
increased likelihood
esophageal adenocarcinoma
Prior art date
Application number
HK15109503.4A
Other languages
English (en)
Chinese (zh)
Inventor
Massimiliano Di Pietro
Rebecca Fitzgerald
Xinxue Liu
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of HK1208886A1 publication Critical patent/HK1208886A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00482Digestive system
    • A61B2018/00488Esophagus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plasma & Fusion (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15109503.4A 2012-05-18 2015-09-25 Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma HK1208886A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1208963.7A GB201208963D0 (en) 2012-05-18 2012-05-18 Methods
PCT/GB2013/051285 WO2013171508A1 (fr) 2012-05-18 2013-05-17 Procédé pour déterminer si un sujet présente une probabilité augmentée de dysplasie de grade élevé ou d'adénocarcinome oesophagien

Publications (1)

Publication Number Publication Date
HK1208886A1 true HK1208886A1 (en) 2016-03-18

Family

ID=46546452

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109503.4A HK1208886A1 (en) 2012-05-18 2015-09-25 Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma

Country Status (5)

Country Link
US (1) US20150168409A1 (fr)
EP (1) EP2850208B1 (fr)
GB (1) GB201208963D0 (fr)
HK (1) HK1208886A1 (fr)
WO (1) WO2013171508A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133935A2 (fr) * 2010-04-22 2011-10-27 The Johns Hopkins University Procédés et kits pour évaluation des risques de la progression néoplasique de barrett
ES2721539T3 (es) * 2011-09-23 2019-08-01 Acad Medisch Ct Materiales y métodos para pronóstico de evolución de esófago de Barrett

Also Published As

Publication number Publication date
US20150168409A1 (en) 2015-06-18
EP2850208A1 (fr) 2015-03-25
WO2013171508A1 (fr) 2013-11-21
GB201208963D0 (en) 2012-07-04
EP2850208B1 (fr) 2017-07-19

Similar Documents

Publication Publication Date Title
SG11201504241QA (en) Method for evaluation of presence of or risk of colon tumors
EP2919028A4 (fr) Procédé de détection d'état de dispositif de stockage
EP2741085A4 (fr) Procédé de détection du cancer du pancréas
GB201301281D0 (en) A Method of detecting structural parts of a scene
PT2901370T (pt) Processo de detecção de uma face real
SG11201404814UA (en) A method of target detection
PL2901695T3 (pl) Sposób przetwarzania jednego lub większej liczby obrazów wideo sceny trójwymiarowej
PT2876447T (pt) Método para deteção de cancro
LU92173B1 (en) Distance determination method
HK1221381A1 (zh) 治療吞咽障礙的方法
PL3019382T3 (pl) Sposób określania położenia zadanego toru kolejowego
EP2840381A4 (fr) Procédé pour la détection de particules cibles
PL2876446T3 (pl) Sposób wykrywania nowotworu
PT3249109T (pt) Método de aterro de entulho de fundo do mar
HK1208731A1 (en) Method for the detection of a multispecific binder
HK1208885A1 (en) Methods to assess the likelihood of dysplasia or esophageal adenocarcinoma
EP2985605A4 (fr) Méthode de détection du cancer du colon
EP2913660A4 (fr) Méthode de détection de particules cibles
EP2818850A4 (fr) Procédé de détection de particules cibles
EP2752666A4 (fr) Marqueur de détection du cancer du côlon et du rectum ou du cancer de l' sophage et méthode de dépistage associée
AP2014007806A0 (en) Method for floating
HK1200499A1 (en) Method for identifying aptamers
EP2981810C0 (fr) Procédé de détermination d'une propriété d'un milieu hétérogène
EP2927205A4 (fr) Procédé de production d'aldéhyde
SG11201601761QA (en) Method for detection of a genetic variant